Cancer treatment system
By integrating magnetic field measuring instruments and temperature measuring instruments in cancer treatment equipment, the problem of difficulty in monitoring the magnetic field size and temperature of existing equipment is solved, and effective control and safety monitoring of AC magnetic field treatment is achieved.
Patent Information
- Application Number
- CN202380035752.9
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Priority Date
- 2022-04-28
- Filing Date
- 2023-04-25
- Publication Date
- 2024-12-03
AI Technical Summary
Existing AC magnetic field cancer treatment equipment is difficult to effectively monitor the size and temperature of the magnetic field when applying a magnetic field, which affects the treatment effect.
A cancer treatment system including a magnetic field generator and a magnetic field measuring device is designed to ensure that the magnetic field applied to the affected area is within a predetermined range and does not depend on the heating of the magnetic field by measuring the magnitude and temperature of the alternating magnetic field generated by the magnetic field generator. effect.
Real-time monitoring and temperature control of the magnetic field applied to the affected area is achieved, ensuring the stability and safety of the treatment effect, and avoiding treatment interruptions caused by excessive temperature.
Smart Images

Figure CN119072345A_ABST
Abstract
Description
Technical Field
[0001] The present disclosure relates to a cancer treatment system. Background Art
[0002] Various types of cancer treatment devices are known as treatment devices for treating cancer.
[0003] Patent Document 1 and Patent Document 2 disclose a cancer treatment device for treating cancer using an alternating current magnetic field. Summary of the invention
[0004] Technical issues
[0005] In the cancer treatment apparatus disclosed in Patent Document 1 and Patent Document 2, when a magnetic field is applied to an affected area by an alternating magnetic field, the magnitude of the magnetic field itself applied to the affected area effectively suppresses the proliferation of cancer cells. When the cancer treatment apparatus is used, the temperature around the affected area to which the alternating magnetic field is applied may increase, so it is necessary to monitor the temperature. When the cancer treatment apparatus is used, in order to suppress the proliferation of cancer cells in the affected part, it is also necessary to monitor the amount and number of hours of the magnetic field applied to the affected part in a cumulative manner.
[0006] The present disclosure provides a cancer treatment apparatus that monitors a magnetic field applied to an affected area and / or monitors a temperature increase in the affected area.
[0007] Solution to the problem
[0008] According to an embodiment of the present invention, a cancer treatment system includes: a magnetic field generator configured to generate an alternating magnetic field to be applied to a cancer-affected site; a magnetic field measuring device configured to measure the magnitude of the magnetic field generated by the magnetic field generator, wherein the cancer-affected site is inserted into the magnetic field generated by the magnetic field generator to treat cancer. A cancer treatment system includes a magnetic field generator configured to generate an alternating magnetic field to be applied to a cancer-affected site; a temperature measuring device configured to measure the temperature of the cancer-affected site or the surrounding area of the cancer-affected site, wherein the cancer-affected site is inserted into the magnetic field generated by the magnetic field generator to treat cancer without using a heat-generating medium and without relying on a high thermal effect utilizing the heat-generating effect of a magnetic field.
[0009] Advantageous Effects of the Invention
[0010] According to the cancer treatment apparatus of the present disclosure, the magnetic field applied to the affected area may be monitored, and / or the temperature increase of the affected area may be monitored. BRIEF DESCRIPTION OF THE DRAWINGS
[0011] Figure 1 is a top view of a cancer treatment device in use according to this embodiment;
[0012] Figure 2 is a front view of a cancer treatment device in use according to the present embodiment;
[0013] Figure 3 is a side view of a cancer treatment device in use according to the present embodiment;
[0014] Figure 4 is a perspective view of a magnetic field generator in a cancer treatment device according to the present embodiment;
[0015] Figure 5 is a cross-sectional perspective view of a magnetic field generator in a cancer treatment device according to the present embodiment;
[0016] Figure 6 is a perspective view of a magnetic field measuring device in a cancer treatment system according to a first embodiment;
[0017] Figure 7 is a top view showing magnetic field measurement in the cancer treatment system according to the first embodiment;
[0018] Figure 8 is a top view showing magnetic field measurement in the cancer treatment system according to the first embodiment;
[0019] Fig. 9 is a flowchart showing a magnetic field measurement process in the cancer treatment system according to the first embodiment;
[0020] Fig.10 is a side view showing temperature measurement in a cancer treatment system according to a second embodiment;
[0021] Fig.11 is a side view showing temperature measurement in a cancer treatment system according to a second embodiment;
[0022] Fig.12 is a front view showing temperature measurement in a cancer treatment system according to a second embodiment;
[0023] Fig.13 is a flowchart showing a temperature measurement process in a cancer treatment system according to a second embodiment;
[0024] Fig.14 is a side view showing temperature measurement and magnetic field measurement in a cancer treatment system according to a modified embodiment; and
[0025] Fig.15 is a side view showing temperature measurement and magnetic field measurement in a cancer treatment system according to a modified embodiment. DETAILED DESCRIPTION
[0026] Hereinafter, embodiments of the present invention will be described with reference to the accompanying drawings. In this specification and the accompanying drawings, constituent elements having substantially the same functional configuration are represented by the same reference numerals, and redundant descriptions are omitted. For ease of understanding, the proportions of the various parts in the accompanying drawings may be different from the actual proportions.
[0027] In directions such as parallel, right angle, orthogonal, horizontal, vertical, up and down, left and right, deviations are allowed to the extent that the effect of the embodiment is not impaired. The shape of the corner is not limited to a right angle, and can be an arc-shaped circle. Parallel, right angle, orthogonal, horizontal and vertical can respectively include substantially parallel, substantially right angle, substantially orthogonal, substantially horizontal and substantially vertical.
[0028] <<Cancer Treatment Equipment 10>>
[0029] First, the cancer treatment apparatus 10 included in the cancer treatment system according to the present embodiment will be described. Figure 1 is a top view showing the cancer treatment device 10 in use according to the present embodiment. Figure 2 is a front view showing the cancer treatment apparatus 10 in use according to the present embodiment. Figure 3 1 is a side view showing the cancer treatment apparatus 10 in use according to the present embodiment.
[0030] The cancer treatment device 10 is a cancer treatment device that suppresses the proliferation of cancer cells by applying an alternating magnetic field to cancerous tissue. The cancer treatment device 10 is a magnetic treatment device that applies an alternating magnetic field generated by a coil 100a provided in a magnetic field generator 100 to cancerous tissue for treatment. The cancer treatment device 10 is a cancer treatment device that treats a cancerous part by inserting the cancerous part into the alternating magnetic field generated by the magnetic field generator 100.
[0031] The cancer treatment device 10 does not use a heat-generating medium. In addition, the cancer treatment device 10 is not a device that treats cancer by a high thermal effect using the heat-generating effect of a magnetic field, but a cancer treatment device that treats cancer by directly applying an alternating magnetic field to a cancer-affected part by the magnetic field generator 100. The cancer treatment device 10 is, for example, a cancer treatment device that treats cancer by a high thermal effect using the heat effect of a magnetic field using a heat-generating medium. In other words, the cancer treatment device 10 is a cancer treatment device that treats a cancer-affected part by inserting the cancer-affected part into an alternating magnetic field generated by the magnetic field generator 100 without using a heat-generating medium and does not rely on a high thermal effect using the heat-generating effect of a magnetic field.
[0032] The cancer treatment apparatus 10 includes a magnetic field generator 100, a power supply 101, a matching unit 102, and a cooler 103. The cancer treatment apparatus 10 also includes a treatment table 106 on which a patient P lies.
[0033] The magnetic field generator 100 generates an alternating magnetic field to be applied to an affected part of the patient P. The magnetic field generator 100 receives current supplied from a power source 101. The power source 101 stably supplies current to the magnetic field generator 100 at a target resonant frequency (e.g., 230 kilohertz (kHz)) through a matching unit 102. The magnetic field generator 100 converts the current supplied by the power source 101 into a magnetic field by electromagnetic induction. The magnetic field generator 100 is formed of, for example, a coil.
[0034] The power supply 101 supplies a current for generating a magnetic field to the magnetic field generator 100. The power supply 101 is connected to a power supply PS, for example, a commercial power supply. The power supply 101 generates an alternating current having a frequency of, for example, 100 kHz to 300 kHz using the power supplied from the power supply PS. The power supply 101 supplies the generated alternating current to the magnetic field generator 100 via the matching unit 102. The power supply 101 adjusts the current so as to generate an alternating magnetic field having a desired magnetic flux density in the magnetic field generator 100.
[0035] The matching unit 102 performs impedance matching between the power supply 101 and the magnetic field generator 100. The matching unit 102 includes a known resonant circuit, such as a series circuit or a parallel circuit including an inductor, a capacitor, and a resistor. The matching unit 102 has a control function of adjusting the frequency so that the magnetic field generator 100 can always output a maximum current value. The matching unit 102 provides a stable current to the magnetic field generator 100.
[0036] The magnetic field generator 100 generates an alternating magnetic field at a location where the affected part is placed (e.g., the center of the coil 100a), wherein current is supplied to the magnetic field generator 100 from the power supply 101 via the matching unit 102. The magnetic flux density of the alternating magnetic field generated by the magnetic field generator 100 is, for example, 10 to 30 milliteslas (mT). The alternating magnetic field generated by the magnetic field generator 100 may have a substantially constant intensity, or may have a pattern in which a waveform with a specific amplitude variation is repeated for a predetermined time. That is, the alternating magnetic field generated by the magnetic field generator 100 may have a pattern in which a waveform with a predetermined amplitude variation including a substantially constant waveform is repeated for a predetermined time.
[0037] The cooler 103 supplies a coolant to cool the magnetic field generator 100. The magnetic field generator 100 generates heat when current is supplied from the power source 101. The cancer treatment apparatus 10 cools the magnetic field generator 100 using the coolant supplied by the cooler 103.
[0038] The cooler 103 supplies a coolant for cooling the magnetic field generator 100. The cooler 103 recovers the coolant that has cooled the magnetic field generator 100. The cooler 103 circulates the coolant while maintaining the temperature of the liquid at a constant level. The cooler 103 is, for example, a refrigerator. The cooler 103 is connected to a power source PS, which is, for example, a commercial power source. The cooler 103 uses the power from the power source PS to cool the coolant. The cooler 103 supplies the coolant for cooling the magnetic field generator 100 to the magnetic field generator 100. The coolant may be, for example, water, water to which an antifreeze solution is added, or an inert liquid such as a fluorinated liquid.
[0039] The cooler 103 supplies the coolant to the manifold 104 through the hose 105. The manifold 104 supplies the coolant supplied from the cooler 103 to the magnetic field generator 100. The manifold 104 recovers the coolant supplied from the magnetic field generator 100.
[0040] In the cancer treatment apparatus 10, the coolant supplied from the cooler 103 may be branched by the manifold 104 and supplied to, for example, the power supply 101 and the matching unit 102. That is, the cancer treatment apparatus 10 may cool at least one of the power supply 101 and the matching unit 102 using the coolant supplied from the cooler 103.
[0041] The cancer treatment apparatus 10 includes a non-conductive buffer material 109 on a treatment table 106. When the treatment table 106 includes metal, the linkage of the alternating magnetic field generated by the magnetic field generator 100 generates eddy currents, and the treatment table 106 generates heat. In order to prevent the treatment table 106 from heating, the cancer treatment apparatus 10 includes a non-conductive buffer material 109 so as to separate the treatment table 106 from the magnetic field generator 100 by a sufficient distance. The patient P lies in a supine position on the non-conductive buffer material 109. For example, it is assumed that the affected part of the patient P is a brain tumor, such as a glioblastoma in the head. The patient P inserts his / her head into the magnetic field generator 100. The magnetic field generator 100 has a shape into which the head of the patient P can be inserted. The magnetic field generator 100 applies a magnetic field to the head of the patient P.
[0042] The configuration of the magnetic field generator 100 will be described. Figure 4 is a perspective view of a magnetic field generator 100 in a cancer treatment apparatus 10 used in a cancer treatment system according to the present embodiment.
[0043] The magnetic field generator 100 includes a coil 100a and a pipe 100b. The material constituting each of the coil 100a and the pipe 100b includes a material having conductivity. Each of the coil 100a and the pipe 100b is constituted by a hollow tubular member. Each of the coil 100a and the pipe 100b is not limited to a cylindrical shape, and may be, for example, an elliptical cylindrical shape or a rectangular cylindrical shape. As an example, Figure 4The coil 100a is shown to have a cylindrical shape.
[0044] The coil 100a has a spiral shape. The patient P inserts the affected part into the inner side 100ai of the coil 100a. The pipe 100b is connected to both ends of the coil 100a.
[0045] A temperature-controlled coolant supplied by the cooler 103 flows inside each of the coil 100a and the pipe 100b. In addition, current flows from the power supply 101 to each of the coil 100a and the pipe 100b via the matching unit 102. The heat generated by the current flowing through the coil 100a and the pipe 100b is cooled by the coolant flowing through the coil 100a and the pipe 100b. By cooling with the coolant, the coil 100a and the pipe 100b maintain a constant temperature.
[0046] Next, an insulating structure included in the coil 100a will be described. When the patient P comes into contact with the coil 100a, the patient P may receive an electric shock. The coil 100a has an insulating structure to prevent electric shock. Figure 5 is a cross-sectional perspective view of the magnetic field generator 100 in the cancer treatment apparatus 10 according to the present embodiment. Figure 5 An example of the coil 100 a having a rectangular cylindrical shape is shown.
[0047] The coil 100a includes a metal tube 100a1, an insulating sheet 100a2, and a protective sheet 100a3. The metal tube 100a1 is made of a metal material such as copper. The insulating sheet 100a2 is an insulating tape, such as a polyimide tape. The protective sheet 100a3 is an insulating sheet, such as a glass sheet. Since the coil 100a includes the insulating sheet 100a2 and the protective sheet 100a3 surrounding the metal tube 100a1, the insulating sheet 100a2 and the protective sheet 100a3 protect the metal tube 100a1. In addition, the insulating sheet 100a2 and the protective sheet 100a3 insulate the metal tube 100a1 from the patient P or the like.
[0048] A protective material such as cloth or rubber may be further provided on the outer side of the protective sheet 100a3 included in the coil 100a. By further providing a protective material such as cloth or rubber on the outer side of the protective sheet 100a3 included in the coil 100a, insulation from the human body can be reliably maintained.
[0049] <<Cancer Treatment System 1>>
[0050] Next, a cancer treatment system 1 according to a first embodiment will be described. The cancer treatment system 1 includes a cancer treatment apparatus 10 and a magnetic field measurer 107. In the present disclosure, the cancer treatment system 1 is described, but the cancer treatment apparatus 10 and the magnetic field measurer 107 may be combined to form a cancer treatment apparatus.
[0051] Patent document 1 discloses that when a magnetic field having a magnetic flux density of about 20 mT is applied to a cancerous part, the growth of cancer is suppressed. Cancer treatment system 1 is based on the technology disclosed in patent document 1 for suppressing the proliferation of cancer cells by applying a magnetic field without heating the cancerous part. In cancer treatment system 1, the amount of magnetic field applied to the affected part is very important for the treatment effect. Therefore, in cancer treatment system 1, it is necessary to confirm by measurement whether a magnetic field having a desired magnetic flux density is being applied to the affected part.
[0052] The magnetic field measurer 107 included in the cancer treatment system 1 will be described. Figure 6 is a perspective view of the magnetic field measurer 107 in the cancer treatment system 1 according to the first embodiment.
[0053] The magnetic field measuring device 107 measures the intensity of the AC magnetic field generated by the magnetic field generator 100. The magnetic field measuring device 107 is, for example, a search coil.
[0054] The measurement and monitoring of magnetic fields are common techniques in other industries. The cancer treatment system 1 according to the present embodiment includes a search coil to measure a magnetic field that fluctuates at a frequency of 230kHz and has a magnetic flux density of about 20mT. The cancer treatment system 1 measures the AC voltage induced by the AC magnetic field in the search coil, and uses, for example, a correspondence table between voltage and magnetic field to obtain the magnitude of the magnetic field, specifically, the magnetic flux density. In the cancer treatment system 1, the magnetic field can be measured by a gauss meter.
[0055] The magnetic field measuring device 107 is supported by a supporting unit 111. Figure 6 As shown, the support unit 111 can move along the corresponding directions of the X, Y and Z axes in a three-dimensional coordinate system composed of mutually orthogonal X, Y and Z axes. Specifically, the support unit 111 moves the magnetic field measurer 107 by a set distance along the X-axis direction Dx, the Y-axis direction Dy and the Z-axis direction Dz.
[0056] The magnetic field measurement using the magnetic field measurer 107 in the cancer treatment system 1 will be described. First, the magnetic field measurement performed before treatment in the cancer treatment system 1 will be described. Figure 7 1 is a top view showing magnetic field measurement performed before treatment in the cancer treatment system 1 according to the first embodiment.
[0057] In the cancer treatment system 1 , before treating the patient P, the magnetic field generated by the magnetic field generator 100 is measured.
[0058] On the other hand, the magnetic field generator 100 generates a magnetic field through the coil 100a. The magnetic flux interlinked with the coil such as the coil 100a changes even with a slight position difference. Therefore, it is necessary to determine the magnetic field at the position where the affected part is actually located in the magnetic field generator 100 by performing actual measurement.
[0059] In the cancer treatment system 1 according to the first embodiment, before treating the patient P, the magnetic field at the position where the affected part of the patient P is located in the magnetic field generator 100 is measured using the magnetic field measurer 107 .
[0060] The cancer treatment system 1 includes: a detection circuit (not shown), which detects the voltage generated by the magnetic field in the search coil as a magnetic field measurer 107; a magnetic field strength recorder 108, which acquires the voltage signal obtained by the detection circuit and then calculates and records the magnetic field strength; and a magnetic field strength display 110, which displays the size of the magnetic field recorded by the magnetic field strength recorder 108.
[0061] The cancer treatment system 1 controls the support unit 111 to measure the magnetic field generated in the magnetic field generator 100 through the magnetic field measurer 107. Then, the cancer treatment system 1 records the measurement result through the magnetic field strength recorder 108.
[0062] The magnetic field near the magnetic field generator 100 is also measured to estimate the magnetic field at the location (treatment location) where the affected part of the patient P is located during the treatment of the patient P described below. Then, the correspondence between the magnetic field at the location where the affected part of the patient P is located and the magnetic field near the magnetic field generator 100 is calculated.
[0063] Next, magnetic field measurement performed when performing treatment in the cancer treatment system 1 will be described. Figure 8 is a top view showing magnetic field measurement performed during treatment in the cancer treatment system 1 according to the first embodiment.
[0064] As described above, the amount of magnetic field applied to the affected part is very important for the treatment effect in the cancer treatment system 1. Therefore, it is necessary to confirm by measurement whether a magnetic field with a desired magnetic flux density is applied to the affected part during actual treatment in the cancer treatment system 1.
[0065] In the cancer treatment system 1 according to the first embodiment, the magnetic field near the magnetic field generator 100 is measured using the magnetic field measurer 107 during treatment of the patient P. In the cancer treatment system 1, the magnetic field measurer 107 is provided near the magnetic field generator 100, that is, around the treatment position. The cancer treatment system 1 estimates the magnetic field at the position of the affected part of the patient P in the magnetic field generator 100 by measuring the magnetic field near the magnetic field generator 100.
[0066] During the actual treatment of the patient P, the magnetic field at the location of the affected part of the patient P cannot be measured because the affected part of the patient P is located in the magnetic field generator 100. The cancer treatment system 1 estimates the magnetic field at the location of the affected part of the patient P based on the measurement result of the magnetic field near the magnetic field generator 100.
[0067] The magnetic field strength recorder 108 is, for example, a personal computer. The magnetic field strength recorder 108 converts the voltage signal generated by the magnetic field in the search coil into magnetic flux density through a software program. For example, the magnetic field strength recorder 108 can use a correspondence table to convert the voltage signal into magnetic flux density, or can use a conversion formula to convert the voltage signal into magnetic flux density.
[0068] In addition, the magnetic field strength recorder 108 can determine whether the magnetic flux density is within a range from a predetermined upper limit value to a predetermined lower limit value of the target magnetic flux density. For example, if the magnetic field strength exceeds the target predetermined upper limit value or is lower than the target predetermined lower limit value, the magnetic field strength recorder 108 can generate a warning sound or can display a warning on the magnetic field strength display 110.
[0069] The magnetic field strength recorder 108 can issue a warning and make the medical staff such as doctors who are performing the treatment aware of the warning. The medical staff can make a decision to stop the treatment based on the warning. In addition, in the cancer treatment system 1, the current value output by the power supply 101 can be adjusted so that the magnetic field strength falls within the range between the upper limit value and the lower limit value. The adjustment of the current output by the power supply 101 can be automatically performed by the magnetic field strength recorder 108, or can be manually set by the medical staff performing the treatment.
[0070] Next, the process of the cancer treatment system 1 will be described. Fig. 9 1 is a flowchart for explaining the magnetic field measurement process in the cancer treatment system 1 according to the first embodiment.
[0071] (Step S10)
[0072] First, the cooler 103 is activated. When the power of the cooler 103 is turned on to start the cooler 103, the cooler 103 adjusts the temperature of the coolant to a predetermined target temperature. The cooler 103 supplies the temperature-adjusted coolant to the coil 100a of the magnetic field generator 100. The cooler 103 recovers the coolant supplied to the coil 100a. That is, the coolant whose temperature is adjusted by the cooler 103 circulates between the cooler 103 and the coil 100a of the magnetic field generator 100.
[0073] (Step S20)
[0074] Next, the power source 101 is activated. The power source 101 is turned on so that power can be supplied from the power source 101 to the magnetic field generator 100 .
[0075] (Step S30)
[0076] Next, the power supply 101 starts supplying current to the coil 100a included in the magnetic field generator 100. For example, a current supply switch included in the power supply 101 is turned on. When the current supply switch is turned on, the power supply 101 starts supplying current to the coil 100a.
[0077] (Step S40)
[0078] Next, the support unit 111 is controlled to insert the magnetic field measurer 107 into the coil 100a of the magnetic field generator 100. Then, the magnetic field measurer 107 measures the magnetic flux density inside the coil 100a, that is, the position where the affected part of the patient P is located during treatment. For example, when the magnetic field measurer 107 is a search coil, the AC voltage generated in the search coil is measured.
[0079] The magnetic field measurement device 107 may be inserted into a plurality of locations inside the coil 100 a or into a single point on the central axis of the coil 100 a .
[0080] The magnetic field strength recorder 108 records the result measured by the magnetic field measurer 107. The magnetic field strength recorder 108 displays the measurement result on the magnetic field strength display 110.
[0081] The support unit 111 inserts the magnetic field measurer 107 into the coil 100a of the magnetic field generator 100. For example, the support unit 111 may be inserted by automatically extending an arm by a motor, etc. Alternatively, a person measuring the magnetic field may directly insert the magnetic field measurer 107 into the coil 100a.
[0082] (Step S50)
[0083] Next, the person measuring the magnetic field confirms the difference between the measurement result of the magnetic flux density displayed on the magnetic field intensity display 110 and the predetermined target value of the magnetic flux density. When the difference between the measured value of the magnetic flux density and the target value of the magnetic flux density is within the prescribed range and no problem is found in the measurement, the magnetic field measurer 107 is retracted from the inside of the coil 100a. For example, when the difference between the measured value of the magnetic flux density and the target value of the magnetic flux density exceeds the prescribed range, that is, when the measured value exceeds the predetermined upper limit value or the predetermined lower limit value, the predetermined current value of the power supply 101 is adjusted.
[0084] For example, the predetermined current value of the power source 101 may be automatically adjusted by connecting the magnetic field strength recorder 108 to the power source 101 .
[0085] (Step S60)
[0086] Next, the supply of current from the power supply 101 to the magnetic field generator 100 is stopped. For example, a current supply switch included in the power supply 101 is turned off. When the current supply switch is turned off, the power supply 101 stops supplying current to the coil 100a.
[0087] Note that steps S10, S20, S30, S40, S50, and S60 are pre-treatment processes.
[0088] (Step S70)
[0089] Next, the patient P lies supinely on the treatment table 106 of the cancer treatment apparatus 10. Here, it is assumed that the patient P has an affected part on the head. For example, it is assumed that the affected part of the patient P is brain cancer. The patient P inserts his or her head as the affected part into the coil 100a of the magnetic field generator 100.
[0090] (Step S80)
[0091] Next, the support unit 111 moves the magnetic field measurer 107 to the vicinity of the magnetic field generator 100 and determines the position. The magnetic field measurer 107 is located near the end surface of the coil 100a and is located at a position that does not contact the patient P. The magnetic field measurer 107 is located at an appropriate position, which depends on, for example, the position of the affected part of the patient P.
[0092] During treatment, the support unit 111 moves and fixes the magnetic field measurer 107 to a suitable position outside the coil 100a so as not to contact the patient.
[0093] (Step S90)
[0094] Next, the power supply 101 starts to supply current to the coil 100a included in the magnetic field generator 100. That is, in the cancer treatment system 1, the power supply 101 supplies current to the magnetic field generator 100. For example, a current supply switch included in the power supply 101 is turned on. When the current supply switch is turned on, the power supply 101 starts to supply current to the coil 100a.
[0095] (Step S100)
[0096] The magnetic field generator 100 continuously applies the magnetic field to the affected part of the patient P for a period of time. In other words, the magnetic field generator 100 keeps applying the magnetic field to the affected part of the patient P for a period of time. For example, when the treatment time is 30 minutes, the magnetic field generator 100 applies the magnetic field to the affected part of the patient P for 30 minutes. When the magnetic field generator 100 applies the magnetic field, the patient P should remain as still as possible.
[0097] (Step S110)
[0098] The cancer treatment system 1 records the magnetic flux density measured by the magnetic field measurer 107 while applying a magnetic field to the affected part of the patient P. The magnetic field measurer 107 measures the magnetic flux density while applying a magnetic field to the affected part of the patient P, and outputs the measurement result to the magnetic field strength recorder 108. The magnetic field strength recorder 108 records the result measured by the magnetic field measurer 107. For example, when the magnetic field measurer 107 is a search coil, the magnetic field strength recorder 108 obtains the output voltage measured by the search coil. Then, the magnetic field strength recorder 108 calculates the magnetic flux density at the position where the search coil is located through a correspondence table or formula. Then, based on the calculated magnetic flux density, the magnetic flux density at the position where the affected part of the patient P is located in the coil 100a is calculated through a correspondence table or formula.
[0099] During the treatment, it is necessary to monitor whether the calculated magnetic flux density is generated at the center of the coil to be the same as the magnetic flux density measured in step S40. The magnetic field intensity recorder 108 records the value of the magnetic flux density at appropriate time intervals, such as every minute.
[0100] (Step S120)
[0101] After a predetermined period of time has passed and the magnetic field is continuously applied to the affected part of the patient P for a predetermined period of time, the current supplied from the power supply 101 to the magnetic field generator 100 is stopped and the treatment ends. For example, if the predetermined treatment time is 30 minutes, the treatment ends when the magnetic field generator 100 applies the magnetic field for 30 minutes.
[0102] (Step S130)
[0103] The patient P then sits up and gets down from the treatment table 106. Then, the patient P leaves the cancer treatment apparatus 10. The patient P away from the cancer treatment apparatus 10 moves to, for example, a waiting room or the like.
[0104] (Step S140)
[0105] The magnetic field measurer 107 retracts to a predetermined storage position. Then, the magnetic field measurer 107 stops operating.
[0106] (Step S150)
[0107] Next, the power supply 101 stops operating. Specifically, the power of the power supply 101 is stopped. For example, a power switch included in the power supply 101 is turned off.
[0108] (Step S160)
[0109] Next, the cooler 103 stops its operation. Specifically, the power of the cooler 103 is stopped. For example, a power switch included in the cooler 103 is turned off.
[0110] The magnetic field strength recorder 108 can compare the magnetic field strength measured during treatment with a predetermined upper limit value and a predetermined lower limit value, and determine whether the magnetic field strength is normal or abnormal through the comparison result. If the monitored magnetic flux density exceeds the predetermined upper limit value or falls below the predetermined lower limit value during treatment, the cancer treatment system 1 can immediately notify the medical staff, such as a doctor, who is performing the treatment, by sounding a warning or by displaying a warning on the magnetic field strength display 110. The medical staff can make a decision to stop the treatment based on the warning.
[0111] The treatment performed by the cancer treatment device 10 is performed, for example, three times a week for three weeks, and the above treatment is counted as one time. Then, the effect of suppressing the proliferation of cancer cells or suppressing cancer by the treatment is confirmed by magnetic resonance imaging (MRI), simple X-ray computed tomography (simple X-ray CT), contrast computed tomography, positron emission tomography (PET), etc. The treatment is repeated if necessary. For this purpose, during the treatment, the amount and number of hours of magnetic flux density cumulatively applied to the affected area are recorded as the treatment result by monitoring.
[0112] <Overview>
[0113] According to the cancer treatment system 1 of the present embodiment, in the cancer treatment apparatus 10 that suppresses the proliferation of cancer cells by the alternating magnetic field, it is possible to record whether the magnetic flux density having a magnitude suitable for the treatment purpose is applied to the affected part of the patient. In addition, according to the cancer treatment system 1, the treatment result can be recorded in the cancer treatment apparatus 10. In addition, according to the cancer treatment system 1, information on the treatment result performed by the cancer treatment apparatus 10 can be provided to the doctor.
[0114] The technology disclosed in Patent Document 1 is a cancer treatment device that applies a magnetic field to a patient's affected part. Since the applied magnetic field is invisible, it is not visually known whether the actually required magnetic field is applied to the affected part. Therefore, it is necessary to monitor the magnitude of the magnetic field to determine whether appropriate treatment is being performed.
[0115] The cancer treatment system 1 includes a sensor for monitoring the treatment effect, specifically, a magnetic field measurer 107. The magnetic field measurer 107 includes, for example, a search coil or a gauss meter. In the cancer treatment system 1, by measuring at least one of the magnetic flux density at the position of the affected part before treatment and the magnetic flux density at the position of the affected part not contacting the patient during treatment, it is possible to record whether a magnetic flux density having a size suitable for the purpose of treatment is applied to the affected part.
[0116] The cancer treatment system 1 can be used as a human cancer treatment device. The cancer treatment system 1 is particularly suitable for the treatment of cancer types, such as malignant glioblastoma (glioblastoma), for which current surgical and chemotherapy treatments are less effective. In addition, the treatment target treated by the cancer treatment system 1 is not limited to humans, but can be a pet such as a dog or cat, or a livestock such as a horse. In addition, the cancer types targeted by the cancer treatment system 1 are also applicable to cancers other than glioblastoma. For example, the cancer treatment system 1 can be applied to any treatment of glioblastoma, glioma, pancreatic cancer, breast cancer, malignant melanoma, malignant mesothelioma and oral cancer.
[0117] On the other hand, as a known medical device, a hyperthermia device for treating cancer by generating heat by applying a magnetic field is known. However, hyperthermia monitors temperature, not the magnitude of the magnetic field, because the therapeutic effect is determined by the temperature increase of the affected area.
[0118] By measuring the magnitude of the magnetic field, the cancer treatment system 1 can monitor whether the initially required magnitude of the magnetic field is applied to the cancer affected part before and during treatment. In addition, when an abnormality occurs in which the magnitude of the monitored magnetic field exceeds a predetermined upper limit value or falls below a predetermined lower limit value, the cancer treatment system 1 can issue a warning message to a medical staff (e.g., a doctor) to stop the treatment. In addition, according to the cancer treatment system 1, the magnitude of the monitored magnetic field is recorded as a treatment result, and a treatment record can also be provided, which indicates how much and how many hours the magnitude of the magnetic field was applied to the affected part in a cumulative manner relative to continuous treatment.
[0119] In the cancer treatment system 1 , for example, the magnetic field measurer 107 may use a search coil in the magnetic field measurement before treatment, and the magnetic field measurer 107 may use a gauss meter in the magnetic field measurement during treatment.
[0120] The magnetic field generator 100 generates a magnetic field having a magnetic flux density of several mT. It is desirable to use a search coil to measure a magnetic field having a strong magnetic flux density of about several mT. Therefore, when measuring the magnetic flux density inside the coil 100a before treatment, it is desirable to use a search coil.
[0121] On the other hand, in the magnetic field measurement during treatment, the measurement is performed at a position away from the coil 100a, for example, about 15 cm, so as not to contact the patient P. Since the magnetic flux density becomes 1 mT or less at a position away from the coil 100a, a commercially available Gauss meter can be used to measure the magnetic field at a position where the magnetic flux density is low. For example, the Gauss meter can be fixed at a position about 15 cm away from the end of the coil 100a, so that the magnitude of the magnetic field can be measured all the time before and during treatment.
[0122] A Hall element, a magnetoresistive effect element, or the like can be used as the magnetic field measuring device 107 .
[0123] <<Cancer Treatment System 2>>
[0124] In the cancer treatment apparatus 10, when an alternating magnetic field having a frequency of 230kHz and a magnetic flux density of about 20mT is applied to an affected part, in a medium-sized animal such as a human or a dog, the fluid in the tissue gradually generates heat, and the body temperature rises. The inventors of the present invention have found that, in the cancer treatment apparatus 10, the larger the cross-sectional area of the living body where the magnetic flux intersects, the easier it is to generate heat. In the cancer treatment apparatus 10, since about 70% of the water constituting the living body is an electrolytic solution having conductivity, which generates eddy current due to electromagnetic induction, the larger the cross-sectional area of the living body where the magnetic flux intersects, the easier it is to generate heat.
[0125] Therefore, in the cancer treatment apparatus 10, when the AC magnetic field is applied to the affected part, the state of heat generated due to the eddy current needs to be constantly monitored. In particular, in the cancer treatment apparatus 10, the temperature needs to be continuously monitored. In the cancer treatment apparatus 10, when the temperature of the portion where the AC magnetic field is applied exceeds a predetermined upper limit value, it is necessary to stop the treatment or temporarily stop the generation of the AC magnetic field. Therefore, the cancer treatment system 2 according to the second embodiment includes a temperature measuring device 207 that measures the temperature of the affected part or the surroundings of the affected part to which the magnetic field is applied by the magnetic field generator 100.
[0126] The cancer treatment system 2 includes the cancer treatment apparatus 10 and at least one of a temperature measurer 207 and a temperature measurer 217 for measuring the body temperature of a patient P. Fig.10 207 is a side view showing a case where temperature measurement is performed using a thermal imager in the cancer treatment system 2 according to the second embodiment. The temperature measurement device 207 is, for example, a thermal imager. The temperature measurement device 207 is connected to a temperature recorder 208. The temperature measurement device 207 outputs measured data to the temperature recorder 208. The temperature recorder 208 acquires temperature information measured by the thermal imager as the temperature measurement device 207. The temperature display 210 displays the temperature distribution acquired by the temperature recorder 208.
[0127] The temperature measuring device 207 , which is a thermal imager, measures the surface temperature of the affected part or the surrounding area of the affected part from a position at least 15 cm away from the magnetic field generator 100 .
[0128] The temperature measurer 207 is not limited to the thermal imager. Fig.112 is a side view showing a case where a fiber optic thermometer is used for temperature measurement in the cancer treatment system 2 according to the second embodiment. The temperature measuring device 217 is a fiber optic thermometer. The tip of the optical fiber 217a of the temperature measuring device 217 contacts and is fixed to a plurality of locations such as an affected part, the vicinity of the affected part, and a magnetic field generating device. The temperature measuring device 217 outputs the measured data to the temperature recorder 208.
[0129] Fig.12 1 is a front view showing the installation position of an optical fiber 217a included in a temperature measuring device 217 as an optical fiber thermometer for measuring temperature in the cancer treatment system 2 according to the second embodiment.
[0130] The tip of the optical fiber 217a included in the temperature measuring device 217 as an optical fiber thermometer is located at each of, for example, the forehead PT1, the temple region PT2, and the parietal region PT3 of the head PH of the patient P. Regarding the tip of the temperature measuring device 217 as an optical fiber thermometer, the above example is only an example. For example, the tip of the optical fiber 217a of the temperature measuring device 217 as an optical fiber thermometer can be fixed to at least one of the forehead PT1, the temple region PT2, and the parietal region PT3. In addition, for example, the tip of the optical fiber 217a of the temperature measuring device 217 as an optical fiber thermometer can be fixed to a position other than the forehead PT1, the temple region PT2, and the parietal region PT3.
[0131] The temperature recorder 208 acquires the temperature information measured by the temperature measurer 217. The temperature display 210 continuously displays the temperature information acquired by the temperature recorder 208 during the treatment.
[0132] The temperature recorder 208 determines whether the measured temperature information is between a predetermined upper limit value and a predetermined lower limit value of the target temperature through a software program. The temperature recorder 208 can determine whether the measured temperature information is normal or abnormal by determining whether the measured temperature information is within the range from the predetermined upper limit value to the predetermined lower limit value of the target temperature.
[0133] If the temperature exceeds a predetermined upper limit value of the target or is lower than a predetermined lower limit value of the target, the temperature recorder 208 may generate a warning sound or may display a warning on a temperature display. When the temperature recorder 208 issues a warning, the temperature recorder 208 may make the medical staff (e.g., a doctor) who is performing the treatment aware of the notification. When the temperature recorder 208 issues a warning, the medical staff may choose to, for example, interrupt the treatment. In addition, the current value output by the power supply 101 may be adjusted so that the temperature falls within the range between the upper limit value and the lower limit value. The adjustment of the current value of the power supply 101 may be automatically adjusted, or may be manually set by the medical staff performing the treatment.
[0134] Next, the process of the cancer treatment system 2 will be described. Fig.13 : is a flowchart for explaining the temperature measurement process in the cancer treatment system 2 according to the second embodiment.
[0135] (Step S210)
[0136] First, the cooler 103 is activated. When the power of the cooler 103 is turned on to start the cooler 103, the cooler 103 adjusts the temperature of the coolant to a predetermined target temperature. The cooler 103 supplies the temperature-adjusted coolant to the coil 100a of the magnetic field generator 100. The cooler 103 recovers the coolant supplied to the coil 100a. That is, the coolant whose temperature is adjusted by the cooler 103 circulates between the cooler 103 and the coil 100a of the magnetic field generator 100.
[0137] (Step S220)
[0138] Next, the power source 101 is activated. The power source 101 is turned on so that power can be supplied from the power source 101 to the magnetic field generator 100 .
[0139] (Step S230)
[0140] Next, the patient P lies supinely on the treatment table 106 of the cancer treatment apparatus 10. Here, it is assumed that the patient P has an affected part on the head. For example, it is assumed that the affected part of the patient P is brain cancer. The patient P inserts his or her head as the affected part into the coil 100a of the magnetic field generator 100.
[0141] (Step S240)
[0142] Next, the temperature measuring device is installed. First, the case of using the temperature measuring device 207 will be described. The temperature measuring device 207 is installed at a position where the temperature of the affected part can be measured. In addition, the position where the temperature measuring device 207 is installed is fixed. Then, the temperature measuring device 207 is activated.
[0143] Next, a case of using the temperature measuring device 217 will be described. The tip of the optical fiber 217a as the optical fiber thermometer of the temperature measuring device 217 is fixed to the affected part, the affected part surrounding, the wall surface of the magnetic field generator 100, etc. Then, the temperature measuring device 217 is activated.
[0144] (Step S250)
[0145] Next, the cancer treatment system 2 displays the temperature information captured in the temperature recorder 208 on the temperature display 210 to confirm that the surface temperature of the affected area is at a normal value before the treatment starts.
[0146] Steps S210 , S220 , S230 , S240 , and S250 are pre-treatment processes.
[0147] (Step S260)
[0148] Next, the power supply 101 starts supplying current to the coil 100a included in the magnetic field generator 100. For example, a current supply switch included in the power supply 101 is turned on. When the current supply switch is turned on, the power supply 101 starts supplying current to the coil 100a.
[0149] (Step S270)
[0150] The magnetic field generator 100 continuously applies the magnetic field to the affected part of the patient P for a period of time. In other words, the magnetic field generator 100 keeps applying the magnetic field to the affected part of the patient P for a period of time. For example, when the treatment time is 30 minutes, the magnetic field generator 100 applies the magnetic field to the affected part of the patient P for 30 minutes. When the magnetic field generator 100 is applying the magnetic field, the patient P should remain as still as possible.
[0151] (Step S280)
[0152] If the monitored temperature during treatment exceeds a predetermined upper limit or falls below a predetermined lower limit, the temperature recorder 208 immediately notifies the medical staff, such as a doctor, who is performing the treatment, by sounding a warning or by displaying a warning on the temperature display 210. This allows the medical staff to stop the treatment. The medical staff can also cut off the current supply once.
[0153] (Step S290)
[0154] In the temperature recorder 208, if the monitored temperature drops below the upper limit value, the switch of the current supply may be turned on according to the judgment of the medical staff to resume the treatment.
[0155] (Step S300)
[0156] The medical staff monitors the temperature information displayed on the temperature display 210. The temperature recorder 208 records the temperature information at appropriate time intervals, such as every minute.
[0157] (Step S310)
[0158] After the predetermined time has passed and the magnetic field is continuously applied to the affected part of the patient P for a predetermined period of time, the supply of current from the power supply 101 to the magnetic field generator 100 is stopped, and the treatment ends. For example, if the predetermined treatment time is 30 minutes, the treatment ends when the magnetic field generator 100 applies the magnetic field for 30 minutes.
[0159] (Step S320)
[0160] Next, the medical staff removes the temperature measuring device. The tip of the optical fiber 217a included in the temperature measuring device 217 as an optical fiber thermometer is removed. In addition, the medical staff moves the temperature measuring device 207 as a thermal imager to a position where the patient can move easily.
[0161] (Step S330)
[0162] Next, the cooler 103 stops its operation. Specifically, the power supply to the cooler 103 is stopped. For example, a power switch included in the cooler 103 is turned off.
[0163] (Step S340)
[0164] The patient P then sits up and gets down from the treatment table 106. Then, the patient P leaves the cancer treatment apparatus 10. The patient P away from the cancer treatment apparatus 10 moves to, for example, a waiting room or the like.
[0165] (Step S350)
[0166] Next, the power supply 101 stops its operation. Specifically, the power supply of the power supply 101 is stopped. For example, a power switch included in the power supply 101 is turned off.
[0167] <Overview>
[0168] According to the cancer treatment system 2 of the present embodiment, the state of heat generated by eddy current in the cancer treatment apparatus 10 can be continuously monitored. In particular, the cancer treatment system 2 can continuously monitor the temperature of the portion including the affected part to which the AC magnetic field is applied. In addition, according to the cancer treatment system 2 of the present embodiment, in the cancer treatment apparatus 10, when the temperature of the portion to which the AC magnetic field is applied exceeds a predetermined upper limit value, the treatment can be stopped or the generation of the AC magnetic field can be temporarily stopped.
[0169] In the above description, the cancer treatment system 2 includes both the temperature measurer 207 and the temperature measurer 217 , but may include any one of the temperature measurer 207 and the temperature measurer 217 .
[0170] In the above description, when the temperature is equal to or higher than the upper limit value, the cancer treatment system 2 stops the treatment or temporarily stops the generation of the AC magnetic field. However, the affected part can be cooled without stopping the treatment or temporarily stopping the generation of the AC magnetic field. For example, when the temperature is equal to or higher than the upper limit value, the cancer treatment system 2 can cool the affected part by supplying cold air to the affected part, or can cool the affected part by supplying cooling water to a cooling bag that cools the affected part.
[0171] <Edit>
[0172] In the above description, the cancer treatment system 1 including the magnetic field measurer 107 and the cancer treatment system 2 including the temperature measurer 207 and the temperature measurer 217 have been described. However, the cancer treatment system may perform both magnetic field measurement and temperature measurement.
[0173] In other words, a cancer treatment system includes: a magnetic field generator 100, which is configured to generate an AC magnetic field to be applied to a cancer site; a magnetic field measurer 107, which is configured to measure the size of the magnetic field generated by the magnetic field generator 100; and a temperature measurer 207 or 217, which is configured to measure the temperature around the cancer site including the cancer site, wherein the cancer site is treated by inserting the cancer site into the magnetic field generated by the magnetic field generator 100 without using a heat-generating medium and without relying on a high thermal effect using the heat-generating effect of the magnetic field.
[0174] The temperature measuring device 207 or 217 is generally used to measure the temperature change during the magnetic field application period (during the treatment operation). On the other hand, the magnetic field measuring device 107 is mainly used for adjustment or operation check before treatment, and the magnetic field measuring device 107 can also be used during treatment. When the magnetic field measuring device 107 is used during treatment, the magnitude of the magnetic field strength of the affected part of the patient P needs to be assumed based on the magnetic field strength near the affected part of the patient P, because the position where the magnetic field strength needs to be measured is occupied by the affected part of the patient P.
[0175] The frequency of the alternating magnetic field and the magnitude of the magnetic field in the cancer treatment apparatus 10 are not limited to the above values, and treatment may be performed at other frequencies and other magnitudes of the magnetic field.
[0176] Furthermore, although an example of treating the patient P in a supine position has been described above, the patient P may be treated in a sitting position. When the patient P is treated in a sitting state, the coil 100a of the magnetic field generator 100 is fixed relative to the Figure 1 The magnetic field generator 100 is in a state of being rotated 90° from the vertical direction, that is, the coil 100a of the magnetic field generator 100 is located above the head of the patient P. When the patient P is treated in a sitting position, it is also feasible to measure and monitor the magnitude of the magnetic field.
[0177] Magnetic field measurement can be performed during maintenance and inspection of cancer treatment equipment. In addition, whether magnetic field measurement is performed in the above procedures depends on the instructions of the Ministry of Health, Labor and Welfare when approving cancer treatment equipment.
[0178] Embodiments of the present disclosure include the following aspects.
[0179] <1> A cancer treatment system includes a magnetic field generator and a magnetic field measurer, wherein the magnetic field generator is configured to generate an alternating magnetic field applied to a cancer site, and the magnetic field measurer is configured to measure the size of the magnetic field generated by the magnetic field generator, wherein the cancer site is inserted into the magnetic field generated by the magnetic field generator to treat cancer.
[0180] <2> A cancer treatment system includes a magnetic field generator and a temperature measurement device, wherein the magnetic field generator is configured to generate an AC magnetic field applied to a cancer-affected site, and the temperature measurement device is configured to measure the temperature of the cancer-affected site or the surrounding area of the cancer-affected site, wherein the cancer-affected site is inserted into the magnetic field generated by the magnetic field generator to treat cancer without using a heat-generating medium and without relying on a high thermal effect utilizing the heat-generating effect of the magnetic field.
[0181] <3> according to <1> The cancer treatment system further includes a magnetic field strength recorder configured to record the magnetic field strength measured by the magnetic field measurer.
[0182] <4> according to <2> The cancer treatment system further includes a temperature recorder configured to record the temperature measured by the temperature measuring device.
[0183] <5> according to <3> The cancer treatment system, wherein the magnetic field intensity recorder determines whether the measured magnetic field intensity is normal or abnormal based on a result of comparing a predetermined upper limit value of the target magnetic field intensity and a predetermined lower limit value of the target magnetic field intensity with the measured magnetic field intensity.
[0184] <6> according to <4> The cancer treatment system, wherein the temperature recorder determines whether the measured temperature is normal or abnormal based on a result of comparing a predetermined upper limit value of the target temperature and a predetermined lower limit value of the target temperature with the measured temperature.
[0185] <7> according to <1> The cancer treatment system, wherein the magnetic field measurer includes a search coil, and wherein the search coil is inserted into a location where a magnetic field is to be applied to treat cancer to measure the AC magnetic field before the magnetic field is applied to the cancer site.
[0186] <8> according to <1> The cancer treatment system, wherein the magnetic field measurer includes a search coil, and wherein the search coil is disposed around a location where a magnetic field is to be applied to treat cancer, to measure an alternating magnetic field when the magnetic field is applied to the cancer site.
[0187] <9> according to <1> The cancer treatment system, wherein the magnetic field measurer includes a search coil, wherein the search coil is inserted into a location where a magnetic field is to be applied to treat cancer so as to measure the AC magnetic field before the magnetic field is applied to the cancer site, and wherein the search coil is disposed around the location where a magnetic field is to be applied to treat cancer so as to measure the AC magnetic field when the magnetic field is applied to the cancer site.
[0188] <10> according to <5> or <6> The cancer treatment system, wherein the magnetic field generator includes a coil configured to generate an AC magnetic field, wherein the cancer treatment system further includes a power supply configured to supply an AC voltage to the coil, and wherein when a result is abnormal, supplying current from the power supply to the magnetic field generator is stopped.
[0189] <11> according to <5> or <6> The cancer treatment system, wherein the magnetic field generator comprises a coil configured to generate an AC magnetic field, wherein the cancer treatment system further comprises a power supply configured to provide an AC voltage to the coil, and wherein when a result is abnormal, the magnitude of the current provided from the power supply to the magnetic field generator is adjusted.
[0190] <12> according to <1> In the cancer treatment system, the magnetic field measuring device comprises a Gauss meter.
[0191] <13> according to <1> In the cancer treatment system, the magnetic field measuring device comprises a Hall element.
[0192] <14> according to <1> In the cancer treatment system, the magnetic field measuring device includes a magnetoresistance effect element.
[0193] <15> according to <4> The cancer treatment system, wherein the temperature measuring device includes a thermal imager, and wherein the thermal imager measures the surface temperature of the cancer site and the surrounding area of the cancer site from a position at least 15 cm away from the magnetic field generator, and outputs the measurement data to the temperature recorder.
[0194] <16> according to <4> The cancer treatment system, wherein the temperature measuring device includes a fiber optic thermometer, and wherein the fiber optic thermometer measures the surface temperature of the cancer-affected site and the surrounding area of the cancer-affected site and outputs the measurement data to the temperature recorder.
[0195] <17> according to <3> The cancer treatment system further includes a magnetic field strength display configured to display the magnitude of the magnetic field recorded by the magnetic field strength recorder.
[0196] <18> according to <2> The cancer treatment system further includes a temperature display configured to display temperature.
[0197] <19> according to <1> to <18> The cancer treatment system of any one of the above further comprises a cooler configured to cool the magnetic field generator.
[0198] <20> according to <19> The cancer treatment system, wherein the magnetic field generator comprises a hollow coil, and wherein the cooler supplies a coolant to the coil.
[0199] <21> according to <1> to <20> The cancer treatment system described in any one of the preceding claims, wherein the cancer comprises any one of glioblastoma, glioma, pancreatic cancer, breast cancer, malignant melanoma, malignant mesothelioma and oral cancer.
[0200] <22> A cancer treatment system includes a magnetic field generator configured to generate an alternating current magnetic field applied to a cancer site; a magnetic field measuring device configured to measure the magnitude of the magnetic field generated by the magnetic field generator; and a temperature measuring device configured to measure the temperature around the cancer site including the cancer site, wherein the cancer site is treated by inserting the cancer site into the magnetic field generated by the magnetic field generator without using a heat-generating medium and without relying on a high thermal effect using the heat-generating effect of the magnetic field.
[0201] This international application claims priority from Japanese Patent Application No. 2022-075118 filed on April 28, 2022 and Japanese Patent Application No. 2022-075130 filed on April 28, 2022, the entire contents of Japanese Patent Application Nos. 2022-075118 and 2022-075130 are incorporated herein by reference.
[0202] It should be noted that the present invention is not limited to the configuration described here, such as the configuration described in the above embodiment and the combination of other elements. These points can be changed within the scope not departing from the gist of the present invention and can be appropriately determined according to the application form.
[0203] Reference numerals list
[0204] 1,2 Cancer treatment system
[0205] 10Cancer Treatment Equipment
[0206] 100 Magnetic Field Generator
[0207] 100A coil
[0208] 100a1 Metal pipe
[0209] 100a2 insulation sheet
[0210] 100a3 protective film
[0211] 100b pipe
[0212] 101 Power Supply
[0213] 102 matching units
[0214] 103 Cooler
[0215] 104 Manifold
[0216] 105 hose
[0217] 106 Treatment Table
[0218] 107 Magnetic Field Measuring Device
[0219] 108 Magnetic Field Strength Recorder
[0220] 111 Support Unit
[0221] 109 non-conductive buffer material
[0222] 110 Magnetic Field Strength Display
[0223] 208 Temperature Recorder
[0224] 210 Temperature display
[0225] 207,217 Temperature measuring device
[0226] 217a optical fiber
[0227] Patient P
[0228] PH Head
[0229] PT1 Forehead
[0230] PT2 Temple area
[0231] PT3 Parietal region
[0232] Reference List
[0233] Patent Literature
[0234] [Patent Document 1] Japanese Patent No. 6603812
[0235] [Patent Document 2] Japanese Patent Application Publication No. 2019-201921
Claims
1. A cancer treatment system, comprising: a magnetic field generator configured to generate an alternating magnetic field to be applied to the cancer site; and a magnetic field measurer configured to measure the magnitude of a magnetic field generated by the magnetic field generator, The cancerous part is inserted into a magnetic field generated by a magnetic field generator to treat the cancer.
2. A cancer treatment system comprising: a magnetic field generator configured to generate an alternating magnetic field to be applied to the cancer site; and a temperature measuring device configured to measure a temperature of a cancer-affected area or a surrounding area of the cancer-affected area; The cancer-affected part is inserted into a magnetic field generated by a magnetic field generator to treat the cancer without using a heat-generating medium and without relying on the high thermal effect of the heat generated by the magnetic field. 3 . The cancer treatment system according to claim 1 , further comprising a magnetic field strength recorder configured to record the magnetic field strength measured by the magnetic field measurer. 4 . The cancer treatment system according to claim 2 , further comprising a temperature recorder configured to record the temperature measured by the temperature measurer.
5. The cancer treatment system according to claim 3, The magnetic field intensity recorder determines whether the measured magnetic field intensity is normal or abnormal based on a comparison result between a predetermined upper limit value of the target magnetic field intensity and a predetermined lower limit value of the target magnetic field intensity and the measured magnetic field intensity.
6. The cancer treatment system according to claim 4, The temperature recorder determines whether the measured temperature is normal or abnormal based on a comparison result between a predetermined upper limit value of the target temperature and a predetermined lower limit value of the target temperature and the measured temperature.
7. The cancer treatment system according to claim 1, The magnetic field measuring device comprises a search coil, and The search coil is inserted into a location where a magnetic field is to be applied to treat cancer, so as to measure the AC magnetic field before the magnetic field is applied to the cancerous area.
8. The cancer treatment system according to claim 1, The magnetic field measuring device comprises a search coil, and in, The search coil is disposed around a location where a magnetic field is to be applied to treat cancer to measure an alternating magnetic field when the magnetic field is applied to the cancerous area.
9. The cancer treatment system according to claim 1, The magnetic field measuring device includes a search coil, in, The search coil is inserted into a location where a magnetic field is to be applied to treat cancer to measure the alternating magnetic field before the magnetic field is applied to the cancer site, and The search coil is disposed around a location where a magnetic field is to be applied to treat cancer, so as to measure an alternating magnetic field when the magnetic field is applied to the cancer site.
10. The cancer treatment system according to claim 5 or 6, wherein the magnetic field generator comprises a coil configured to generate an alternating magnetic field, in, The cancer treatment system also includes a power supply configured to provide an alternating voltage to the coil, and When the result is abnormal, supplying current from the power source to the magnetic field generator is stopped.
11. The cancer treatment system according to claim 5 or 6, wherein the magnetic field generator comprises a coil configured to generate an alternating magnetic field, in, The cancer treatment system also includes a power supply configured to provide an alternating voltage to the coil, and When the result is abnormal, the magnitude of the current supplied from the power supply to the magnetic field generator is adjusted.
12. The cancer treatment system according to claim 1, The magnetic field measuring device includes a Gauss meter.
13. The cancer treatment system according to claim 1, The magnetic field measuring device includes a Hall element.
14. The cancer treatment system according to claim 1, The magnetic field measuring device includes a magnetoresistance effect element.
15. The cancer treatment system according to claim 4, The temperature measuring device includes a thermal imager, and The thermal imager measures the surface temperature of the cancerous area and the surrounding area of the cancerous area from a position at least 15 cm away from the magnetic field generator, and outputs the measurement data to the temperature recorder.
16. The cancer treatment system according to claim 4, The temperature measuring device comprises an optical fiber thermometer, and The optical fiber thermometer measures the surface temperature of the cancer-affected area and the surrounding area of the cancer-affected area, and outputs the measured data to the temperature recorder.
17. The cancer treatment system of claim 3, further comprising a magnetic field strength display configured to display the magnitude of the magnetic field recorded by the magnetic field strength recorder.
18. The cancer treatment system of claim 2, further comprising a temperature display configured to display a temperature.
19. The cancer treatment system according to any one of claims 1 to 18, further comprising a cooler configured to cool the magnetic field generator.
20. The cancer treatment system according to claim 19, in, The magnetic field generator includes a hollow coil, and The cooler supplies coolant to the coil.
21. The cancer treatment system according to any one of claims 1 to 20, The cancer includes any one of glioblastoma, glioma, pancreatic cancer, breast cancer, malignant melanoma, malignant mesothelioma and oral cancer.
22. A cancer treatment system comprising: a magnetic field generator configured to generate an alternating magnetic field to be applied to the cancer site; a magnetic field measurer configured to measure the magnitude of a magnetic field generated by the magnetic field generator; and a temperature measuring device configured to measure a temperature around a cancer-affected area including the cancer-affected area, The cancerous part is treated by inserting the cancerous part into a magnetic field generated by a magnetic field generator without using a heat-generating medium and without relying on the high thermal effect of the heat-generating effect of the magnetic field.
